Curcumin as adjuvant therapy to improve remission in myeloma patients: A pilot randomized clinical trial

• المؤلفون الرئيسيون: Damai Santosa (مؤلف), Catharina Suharti (مؤلف), Ignatius Riwanto (مؤلف), Edi Dharmana (مؤلف), Eko Adhi Pangarsa (مؤلف), Budi Setiawan (مؤلف), Suyono Suyono (مؤلف), Mika Lumban Tobing (مؤلف), Suhartono Suhartono (مؤلف), Soeharyo Hadisaputro (مؤلف)
• التنسيق: كتاب
• منشور في: Babol University of Medical Sciences, 2022-02-01T00:00:00Z.
• الموضوعات: article
• الوصول للمادة أونلاين: Connect to this object online.

Background: The treatment for ineligible transplant multiple myeloma is melphalan prednisone. Curcumin has an anti-inflammatory and antiangiogenesis in cancer-directed to nuclear factor-kappa B (NF-kB) pathway. Interleukin 6 (IL-6), vascular endothelial growth factor  (VEGF), tumor necrosis factor-a...